NovoCure Limited (NASDAQ:NVCR) escalated 0.69% and closed its last trading session at $51.41. Its opening price on the last trading day was $51.06. The company’s market cap is $4.85 Billion. The company has 94.36 Million shares outstanding and 75.94 Million shares were floated in market. The short ratio in the company’s stock is documented at 4.5 and the short float is around of 4.65%. NovoCure Limited has been given an analysts’ mean target of 58.
The highest price NVCR stock touched in the last 12 month was $56.67 and the lowest price it hit in the same period was $19.55. Stock’s distance from 52 week High is -9.28% and the distance from 52 week Low is 162.97%.
Share Volume Analysis
A total of 416.36 Million shares exchanged at hands and its average trading volume is standing at 784.79 Million shares. The relative volume of the stock is 0.53.
NovoCure Limited (NASDAQ:NVCR) performance during the last one year upgraded 126.98 percent, while its year to date (YTD) performance showed a positive trend of 53.55 percent. The stock jumped 13.61 percent over the past six months. The stock’s quarterly performance indicates a positive momentum of 47.43 percent, whereas its last one month trend is optimistic with 1.88 percent. Its weekly performance showed upward trend of 6.75 percent.
Profit Margins Analysis
Profitability analysis helps a great deal in making investment decision. Net profit margin of the company was recorded at -25.6 percent, operating profit margin was -13.6 percent, while gross profit margin stands at 67.7 percent.
Key Ratios Review
Liquidity ratios help investors to determine a company’s ability to pay off its debts. For the most recent quarter, quick ratio was 4.6, current ratio was 5, LT Debt/Equity ratio was 1.33 and Total Debt/Equity ratio stands at 1.33, while Payout ratio is 0.
Return on Assets, Investment and Equity
NovoCure Limited (NASDAQ:NVCR) has a Return on Assets of -20 percent, Return on Investment of -19.6 percent and a Return on Equity of -57.1 percent.
Simple Moving Average
Moving averages are used as a strong indicator for technical stock analysis and it helps investors in figuring out where the stock has been and also helps in determining where it may be possibly heading. Now we look at the Moving Averages, the 200-day is 29.88%, the 50-day is 8.83% and the 20-day is -1.36%.
EPS Growth Analysis
The company’s diluted EPS for trailing twelve months was -0.69.
EPS Estimate for the next year is 0.32.
EPS Estimate for the next Quarter is -0.16.
EPS Growth this year is 36.5 percent.
Earnings and Sales Growth
EPS growth for the next 5 years is 0 percent.
Annual EPS growth Past 5 years is 5.9 percent.
Annual Sales Growth in the past 5 years was 88.7 percent.
Quarterly Revenue Growth on year-over-year basis stands at 29.8 percent.
Quarterly Earnings Growth on year-over-year basis stands at 67.2 percent.
Investment Valuation Ratios
The company P/E (price to earnings) ratio is 0 and Forward P/E ratio is 160.66. The company P/S (price to Sales) ratio is 19.55, P/B (price to Book) ratio is 42.49, while its P/C (price to Cash) ratio stands at 19.73.
If we look at the Volatility of NovoCure Limited (NASDAQ:NVCR), Week Volatility is 3.18%, whereas Month Volatility is at 3.58%.
NovoCure Limited (NASDAQ:NVCR)’s RSI (Relative strength index) is at 53.89, its ATR (Average True Range) value is 1.83, while its Beta factor was calculated at 3.29.
Earnings Release Date
The company is estimated to report earnings on Feb 28 BMO.
NovoCure Limited (NASDAQ:NVCR) has an Analysts’ Mean Recommendation of 2.
Insider Ownership and Transactions
NovoCure Limited’s insider ownership stands at 1.8 percent, while its insider transaction is -49.21 percent.
Institutional Ownership and Transactions
Institutional ownership refers to the ownership stake in a company that is held by large financial organizations, pension funds or endowments. NovoCure Limited’s institutional ownership is 71.6%, while its institutional transactions stand at 11.28%.